Advertisement
UK markets open in 4 hours 46 minutes
  • NIKKEI 225

    37,011.63
    -1,068.07 (-2.80%)
     
  • HANG SENG

    16,190.99
    -194.88 (-1.19%)
     
  • CRUDE OIL

    85.20
    +2.47 (+2.99%)
     
  • GOLD FUTURES

    2,423.30
    +25.30 (+1.06%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • Bitcoin GBP

    48,952.52
    -911.06 (-1.83%)
     
  • CMC Crypto 200

    1,263.50
    +377.97 (+40.49%)
     
  • NASDAQ Composite

    15,601.50
    -81.87 (-0.52%)
     
  • UK FTSE All Share

    4,290.02
    +17.00 (+0.40%)
     

Sorrento Therapeutics Plans to Cut Development of Its Coronavirus Vaccine if the Leaders' Vaccines Work

While multiple vaccines have completed phase 3 clinical trials or will in the coming months, Sorrento's lead vaccine, T-VIVA-19, hasn't even entered clinical trials yet. Brian Orelli: You do have a vaccine that you're working on called T-VIVA-19.